U.S. Physical Therapy (NYSE:USPH) Raised to Hold at Zacks Research

U.S. Physical Therapy (NYSE:USPH) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Wednesday,Zacks.com reports.

A number of other analysts have also recently weighed in on USPH. Jefferies Financial Group upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Thursday, March 12th. Citigroup reiterated an “outperform” rating on shares of U.S. Physical Therapy in a research note on Friday, May 8th. Citizens Jmp cut their target price on shares of U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating for the company in a research note on Friday, May 8th. Finally, Barrington Research cut their target price on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research note on Wednesday, May 13th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $97.50.

U.S. Physical Therapy Stock Performance

USPH stock opened at $64.18 on Wednesday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $976.74 million, a price-to-earnings ratio of 128.35, a P/E/G ratio of 1.77 and a beta of 1.21. U.S. Physical Therapy has a 12 month low of $58.19 and a 12 month high of $93.50. The firm has a 50 day moving average of $70.75 and a two-hundred day moving average of $76.91.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Wednesday, May 6th. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.09). The business had revenue of $198.29 million during the quarter, compared to the consensus estimate of $200.94 million. U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.The business’s revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.48 earnings per share. As a group, equities analysts anticipate that U.S. Physical Therapy will post 2.99 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, COO Graham D. Reeve sold 662 shares of the stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $78.86, for a total value of $52,205.32. Following the completion of the transaction, the chief operating officer owned 30,078 shares in the company, valued at approximately $2,371,951.08. This represents a 2.15% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Richard Binstein sold 3,000 shares of the stock in a transaction on Friday, March 6th. The shares were sold at an average price of $81.64, for a total transaction of $244,920.00. Following the completion of the transaction, the executive vice president owned 24,867 shares of the company’s stock, valued at approximately $2,030,141.88. This represents a 10.77% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 2.40% of the company’s stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Large investors have recently made changes to their positions in the company. Hantz Financial Services Inc. grew its holdings in shares of U.S. Physical Therapy by 56.4% in the 4th quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock worth $29,000 after purchasing an additional 132 shares during the last quarter. Advisory Services Network LLC acquired a new stake in U.S. Physical Therapy during the 3rd quarter worth approximately $39,000. EverSource Wealth Advisors LLC raised its holdings in shares of U.S. Physical Therapy by 68.8% in the third quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock valued at $40,000 after purchasing an additional 192 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of U.S. Physical Therapy by 207.1% in the fourth quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock valued at $40,000 after purchasing an additional 348 shares during the last quarter. Finally, iSAM Funds UK Ltd bought a new position in shares of U.S. Physical Therapy in the third quarter valued at $52,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.